Prophylaxis or pre-emptive therapy for CMV in solid organ transplantation?

摘要

The 42nd Interscience Conference on Antimicrobials and Chemotherapy (ICAC) took place in San Diego, California, from 27 to 30 September: Geraldine Flavell, freelance pharmacy writer, reports on the session on virus infections in transplant patients, which contributed further data to the current debate on whether pre-emptive or prophylactic treatment is the optimal therapy for preventing cytomegalovirus disease.